BackZevra Therapeutics Overview
Zevra Therapeutics Inc

Zevra Therapeutics Target Price

Analysts' average 12-month price target for Zevra Therapeutics is $27.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.04

Average Target Price

$26.83143.1% upside

6 analysts in the last 4 months

High: $35 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-27Guggenheim$24117.4% upsideOpen
2026-07-27BTIGKambiz Yazdi$24117.4% upsideOpen
2026-07-27Canaccord GenuitySumant Kulkarni$2081.2% upsideOpen
2026-06-10Maxim GroupJason McCarthy$35217% upsideOpen
2026-06-10GuggenheimEddie Hickman$29162.7% upsideOpen
2026-06-09Canaccord GenuitySumant Kulkarni$29162.7% upsideOpen
2026-05-08GuggenheimEddie Hickman$25126.4% upsideOpen
2026-03-10GuggenheimEddie Hickman$23108.3% upsideOpen
2025-12-30H.C. WainwrightBrandon Folkes$26135.5% upsideOpen
2025-11-06Cantor FitzgeraldKristen Kluska$24117.4% upsideOpen
2025-11-06Canaccord Genuity$24117.4% upsideOpen
2025-03-13Guggenheim$2299.3% upsideOpen
2025-03-12JMP Securities$1863% upsideOpen
2025-02-04GuggenheimZevra Therapeutics to $$2190.2% upsideOpen
2024-09-24Roth CapitalJonathan Aschoff$2190.2% upsideOpen
2024-09-24Maxim GroupJason McCarthy$25126.4% upsideOpen
2024-09-24JMP SecuritiesJason Butler$1754% upsideOpen
2024-09-23H.C. WainwrightOren Livnat$2081.2% upsideOpen
2024-09-18Canaccord GenuitySumant Kulkarni$2299.3% upsideOpen

Zevra Therapeutics (ZVRA) FAQ

Zevra Therapeutics (ZVRA) currently reports a target price of $27. Use the charts on this page to explore Zevra Therapeutics's target price history and peer comparisons.

Analysts' average 12-month price target for Zevra Therapeutics is $27, about 143.1% upside from the current share price of $11.04. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $27, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zevra Therapeutics, and consider following ZVRA for alerts when major investors trade the stock.

Zevra Therapeutics is classified in the Healthcare sector. On target price, it currently shows $27. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZVRA with unrelated industries.